Omeros (OMER) Net Cash Flow (2010 - 2026)
Omeros' (OMER) quarterly Net Cash Flow came in at -$7.8 million in Q1 2026, down 1000.58% year-on-year from $861000.0 in Q1 2025, and down 206.73% quarter-over-quarter from $7.3 million in Q4 2025.
Omeros (OMER) Net Cash Flow (2010 - 2026) Analysis & Trends
Omeros has disclosed Net Cash Flow across 17 years of filings, most recently posting -$7.8 million for Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$7.8 million, down 1000.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 196.91% YoY), and the FY2025 annual result was $6.3 million, up 268.96% from the prior year.
- Net Cash Flow came in at -$7.8 million for Q1 2026 at Omeros, down from $7.3 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $131.4 million in Q3 2022 to a low of -$134.5 million in Q4 2022.
- The 5-year median for Net Cash Flow is $289000.0 (2024), against an average of -$5.8 million.
- Peak annual rise in Net Cash Flow reached 2585.28% in 2022, while the deepest fall reached 6135.23% in 2022.
- Omeros' Net Cash Flow stood at -$134.5 million in 2022, then soared by 82.5% to -$23.5 million in 2023, then jumped by 107.98% to $1.9 million in 2024, then surged by 286.64% to $7.3 million in 2025, then sank by 206.73% to -$7.8 million in 2026.
- The last three Net Cash Flow figures came in at -$7.8 million (Q1 2026), $7.3 million (Q4 2025), and $512000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | -7.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.75 Mn |
| Mar 31, 2026 | -7.75 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 512,000.00 |
| Sep 30, 2025 | 512,000.00 |
| Jun 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | 861,000.00 |
| Mar 31, 2025 | 861,000.00 |
| Dec 31, 2024 | 1.88 Mn |
| Dec 31, 2024 | 1.88 Mn |
| Sep 30, 2024 | -599,000.00 |
| Sep 30, 2024 | -599,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Mar 31, 2024 | -5.27 Mn |
| Mar 31, 2024 | -5.27 Mn |
| Dec 31, 2023 | -23.54 Mn |
| Dec 31, 2023 | -23.54 Mn |